1887

Journal of General Virology header logo

Volume 82, Issue 11

Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys () pre-immunized with a formalin-inactivated RSV vaccine Free

Abstract

The pathology of respiratory syncytial virus (RSV) disease in bonnet monkeys parallels findings with human RSV disease. RSV-infected animals pre-immunized with a formalin-inactivated (FI) RSV vaccine develop inflammation in peribronchiolar, perivascular, interstitial and intra-alveolar sites with lung inflammation scores significantly higher than animals with a primary RSV infection and those pre-immunized with an FI-Vero cell control vaccine (=0·05). Animals previously infected and re-exposed to RSV had significantly lower alveolar, interstitial and total lung inflammation scores than in primary infection (=0·05). Immunization with two intra-muscular doses of 0·5 ml of the FI-RSV vaccine administered 21 days apart resulted in little serum-neutralizing and ELISA antibody, low levels of secretory IgA and a low lymphocyte proliferative response that was significantly lower than the response observed in animals that were previously infected with live RSV. Higher RSV virus titres were detected in the lungs and lung lavage fluid of monkeys immunized with the FI-RSV vaccine than in those with a primary infection (=0·001). RSV was detected by hybridization in pulmonary inflammatory infiltrates, where the single most abundant infiltrating cellular species was macrophages, so it may be these cells that support the enhanced virus replication that contributes to the enhanced pulmonary pathology of FI-RSV immunization.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-11-2663
2001-11-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/11/0822663a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-11-2663&mimeType=html&fmt=ahah

References

  1. Alwan W. H., Kozlowska W. J., Openshaw P. J. M. 1994; Distinct types of lung disease caused by functional subsets of antiviral T cell. Journal of Experimental Medicine 179:81–89
     [Google Scholar]
  2. Becker S., Soukup J., Yankaskas J. R. 1992; Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages. American Journal of Respiratory Cell and Molecular Biology 6:369–374
     [Google Scholar]
  3. Bembridge G. P., Rodriguez N., Garcia-Beato R., Nicolson C., Melero A., Taylor G. 2001; Respiratory syncytial virus infection of gene gun vaccinated mice induces Th-2 driven pulmonary eosinophilia even in the absence of sensitisation to the fusion (F) or attachment (G) protein. Vaccine 19:1038–1046
     [Google Scholar]
  4. Bolen A., Andeweg A., Kwakkel J., Lockhorst W., Bestebroer T., Dormans J., Kimman T. 2001; Both immunization with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV challenged mice. Vaccine 19:982–991
     [Google Scholar]
  5. Chanock R. M., Parrott R. H., Connors M., Collins P. L., Murphy B. R. 1992; Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization. Pediatrics 90:137–143
     [Google Scholar]
  6. Collins P. L., McIntosh K., Chanock R. M. 1996; Respiratory syncytial virus. In Fields Virology pp 1313–1351 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
     [Google Scholar]
  7. Connors M., Kulkarni A. B., Firestone C. Y., Holmes K. L., Morse H. C.III., Sotnikov A. V., Murphy B. R. 1992; Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ cells. Journal of Virology 66:7444–7451
     [Google Scholar]
  8. Connors M., Giese N. A., Kulkarni A. B., Firestone C. Y., Morse H. C.III., Murphy B. R. 1994; Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. Journal of Virology 68:5321–5325
     [Google Scholar]
  9. Domurat F., Roberts N. J. Jr, Walsh E. E., Dagan R. 1985; Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo. Journal of Infectious Diseases 152:895–902
     [Google Scholar]
  10. Fischer J. E., Johnson J. E., Kuli-Zade R. K., Johnson T. R., Aung S., Parker R. A., Graham B. S. 1997; Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. Journal of Virology 71:8672–8677
     [Google Scholar]
  11. Franke-Ullmann G., Pfortner C., Walter P., Steinmuller C., Lohmann-Matthes M. L., Kobzik L., Freihorst J. 1995; Alteration in pulmonary macrophage function by respiratory syncytial virus in vitro. Journal of Immunology 154:268–280
     [Google Scholar]
  12. Fulginiti V. A., Eller J. J., Sieber O. F., Joyner J. W., Minamitani M., Meiklejohn G. 1969; Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines: an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89:435–448
     [Google Scholar]
  13. Graham B. S. 1995; Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. American Journal of Respiratory and Critical Care Medicine 152:S63–S66
     [Google Scholar]
  14. Graham B. S., Henderson G. S., Tank Y. W., Lu X., Neuzil K. M., Colley D. G. 1993; Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. Journal of Immunology 151:2032–2040
     [Google Scholar]
  15. Hussell T., Khan U., Openshaw P. 1997; IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness. Journal of Immunology 159:328–334
     [Google Scholar]
  16. Johnson P. R., Collins P. L. 1989; The 1B (NS2), 1C (NS1) and N proteins of human respiratory syncytial virus (RSV) of antigenic subgroups A and B: sequence conservation and divergence within RSV genomic RNA. Journal of General Virology 70:1539–1547
     [Google Scholar]
  17. Kakuk T. J., Soike K., Brideau R. J. 1993; A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. Journal of Infectious Diseases 167:553–561
     [Google Scholar]
  18. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. 1969; Respiratory syncytial virus diease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422–433
     [Google Scholar]
  19. Midulla F., Huang Y. T., Gilbert I. A., Cirino N. M., McFadden E. R. Jr, Panuska J. 1989; Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. American Review of Respiratory Disease 140:771–777
     [Google Scholar]
  20. Murphy B. R., Prince G. A., Lawrence L. A., Croen K. D., Collins P. L. 1990; Detection of respiratory syncytial virus (RSV) infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin-inactivated virus or purified RSV F and G glycoprotein subunit vaccine and challenged with RSV. Virus Research 16:153–162
     [Google Scholar]
  21. O’Donnell D. R., McGarvey M. J., Tully J. M., Balfour-Lynn I. M., Openshaw P. J. M. 1998; Respiratory syncytial virus RNA in cells from the peripheral blood during acute infection. Journal of Pediatrics 133:272–274
     [Google Scholar]
  22. Openshaw P. J. M., Pemberton R. M., Ball L. A., Wertz G. W., Askonas B. A. 1988; Helper T cell recognition of respiratory syncytial virus in mice. Journal of General Virology 69:305–312
     [Google Scholar]
  23. Panuska J. R., Hertz M. I., Taraf H., Villani A., Cirino N. M. 1992; Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients. American Review of Respiratory Disease 145:934–939
     [Google Scholar]
  24. Piedra P. A., Faden H. S., Camussi G., Wong D. T., Ogra P. L. 1989; Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus. Vaccine 7:34–41
     [Google Scholar]
  25. Piedra P. A., Wyde P. R., Castleman W. L., Ambrose M. W., Jewell A. M., Speelman D. J., Hildreth S. W. 1993; Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine 11:1415–1423
     [Google Scholar]
  26. Ponnuraj E. M., John T. J., Levin M. J., Simoes E. A. F. 1998; Cell-to-cell spread of poliovirus in the spinal cord of bonnet monkeys ( Macaca radiata ). Journal of General Virology 79:2393–2403
     [Google Scholar]
  27. Prince G. A., Jenson A. B., Horswood R. L., Camargo E., Chanock R. M. 1978; The pathogenesis of respiratory syncytial virus infection in cotton rats. American Journal of Pathology 93:771–784
     [Google Scholar]
  28. Prince G. A., Jenson A. B., Hemming V. G. 1986; Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin inactivated virus. Journal of Virology 57:721–728
     [Google Scholar]
  29. Rotbart H. A., Abzug M. J., Murray R. S., Murphy N. L., Levin M. J. 1988; Intracellular detection of sense and antisense enteroviral RNA by in situ hybridization. Journal of Virological Methods 22:295–301
     [Google Scholar]
  30. Simoes E. A. F., Hayward A. R., Ponnuraj E. M., Straumanis J. P., Stenmark K. R., Wilson H., Babu P. G. 1999; Respiratory syncytial virus (RSV) infects the Bonnet monkey, Macaca radiata. Pediatric Pathology 2:316–326
     [Google Scholar]
  31. Srikiatkhachorn A., Braciale T. J. 1997a; Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. Journal of Experimental Medicine 71:421–432
     [Google Scholar]
  32. Srikiatkhachorn A., Braciale T. J. 1997b; Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. Journal of Virology 71:678–685
     [Google Scholar]
  33. Tang Y. W., Graham B. S. 1994; Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. Journal of Clinical Investigation 94:1953–1958
     [Google Scholar]
  34. Vai J. A., Leary P. L., Levin M. J. 1985; Specificity of the blastogenic response of human mononuclear cells to herpes virus antigens. Infection and Immunity 20:646
     [Google Scholar]
  35. Van de Winkel J. G., Capel P. J. A. 1993; Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunology Today 14:215–221
     [Google Scholar]
  36. Waris M. E., Tsou C., Erdman D. D., Zaki S. R., Anderson L. J. 1996; Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2 like cytokine pattern. Journal of Virology 70:2852–2860
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-11-2663
Loading
Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine
J. Gen. Virol. 82, 2663 (2001); https://doi.org/10.1099/0022-1317-82-11-2663
/content/journal/jgv/10.1099/0022-1317-82-11-2663
/content/journal/jgv/10.1099/0022-1317-82-11-2663
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error